Supplementary Data 1 from Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival
Publication
, Other
Ma, KL; Mitchell, TC; Dougher, M; Sharon, CE; Tortorello, GN; Elder, DE; Morgan, EE; Gimotty, PA; Huang, AC; Amaravadi, RK; Schuchter, LM ...
November 1, 2024
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Ma, K. L., Mitchell, T. C., Dougher, M., Sharon, C. E., Tortorello, G. N., Elder, D. E., … Xu, X. (2024). Supplementary Data 1 from Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival. https://doi.org/10.1158/1078-0432.27434035
Ma, Kevin L., Tara C. Mitchell, Meaghan Dougher, Cimarron E. Sharon, Gabriella N. Tortorello, David E. Elder, Eric E. Morgan, et al. “Supplementary Data 1 from Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival,” November 1, 2024. https://doi.org/10.1158/1078-0432.27434035.
Ma KL, Mitchell TC, Dougher M, Sharon CE, Tortorello GN, Elder DE, et al. Supplementary Data 1 from Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival. 2024.
Ma, Kevin L., et al. Supplementary Data 1 from Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival. 1 Nov. 2024. Crossref, doi:10.1158/1078-0432.27434035.
Ma KL, Mitchell TC, Dougher M, Sharon CE, Tortorello GN, Elder DE, Morgan EE, Gimotty PA, Huang AC, Amaravadi RK, Schuchter LM, Flowers A, Miura JT, Karakousis GC, Xu X. Supplementary Data 1 from Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival. 2024.